Johnson & Johnson (NYSE:JNJ)
| 152.12 Delayed Data As of 4:00pm ET |  +0.49 / +0.32%Today’s Change | 144.95 Today|||52-Week Range 181.04 | -13.89% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 151.63 |
| Today’s open | 151.16 |
| Day’s range | 151.12 - 152.20 |
| Volume | 5,190,026 |
| Average volume (3 months) | 17,560,205 |
| Market cap | $367.1B |
Data as of 4:00pm ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -13.84% |
| Earnings growth (this year) | +4.92% |
| Earnings growth (next 5 years) | +2.60% |
| Revenue growth (last year) | +1.34% |
| P/E ratio | 28.5 |
| Price/Sales | 4.95 |
| Price/Book | 5.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +0.57 | +0.56% |
| NONOFNovo Nordisk | +0.95 | +0.94% |
| MRKMerck | +0.94 | +0.94% |
| ABBVAbbVie | +0.44 | +0.32% |
Data as of 4:00pm ET, 11/29/2023
Financials
| Next reporting date | January 23, 2024 |
| EPS forecast (this quarter) | $2.63 |
| Annual revenue (last year) | $95.0B |
| Annual profit (last year) | $17.9B |
| Net profit margin | 18.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
